Adolescent and young adult women with newly diagnosed cancer, requiring anticancer treatment
Conditions
Interventions
None listed
Sponsors
Osaka General Medical Center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female cancer patients undergoing fertility preservation before or during anticancer treatment. 2. Ages at fertility preservation are over 18 and under 43. 3. Patients who can agree with this research.
Exclusion criteria
Exclusion criteria: 1. Patients undergoing ovarian cryopreservation. 2. Patients who are judged by the investigator to be ineligible to participate in this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcomes are serum antimullerian hormone at fertility preservation (baseline), 1 and 2 years later. Odds ratio, 95% CI and p value are calculated using multivariate multiple regression analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are serum FSH level, antral follicle counts, and amenorrhea at fertility preservation (baseline), 1 and 2 years later. Odds ratio, 95% CI and p value are calculated about serum FSH level and antral follicle counts using multivariate multiple regression analysis. Odds ratio, 95% CI and p value are calculated about amenorrhea using logistic regression analysis. | — |
Countries
Japan
Contacts
Public ContactSatoshi Kubota
Osaka General Medical Center Reproductive medicine center
Outcome results
None listed